Azurion and Allura Systems

Performance

Date

2025-01-30

Country

Canada

Classification

Type II

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2025-02-03
2. CA
   Drugs & medicalType I

   Pipeline™ Vantage Embolization Device With Shield Technology™

   Performance

   Health CanadaOfficial notice →
3. 2025-01-31
4. CA
   Drugs & medicalType II

   PMS-FLUOXETINE 10 mg - May contain capsules of PMS-Fluoxetine 20mg.

   Product quality

   Health CanadaOfficial notice →
5. CA
   Drugs & medicalType I

   APO-QUETIAPINE XR - May exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP).

   Product quality

   Health CanadaOfficial notice →
6. 2025-01-30
7. CA
   Drugs & medicalType II

   Medline Endotracheal Tubes

   Labelling and packaging

   Health CanadaOfficial notice →
8. CA
   Drugs & medicalType II

   CIC-C1q - Circulating Immune Complexes (CIC) ELISA

   Performance

   Health CanadaOfficial notice →
9. 2025-01-29
10. CA
    Drugs & medicalType II

    24.0mm, 35.0mm, And 45.0 Mm Acutrak 2 4.7 Screws

    Performance

    Health CanadaOfficial notice →